Prof Dr. ClausGarbe - Oncology Management and Prevention - Lifetime achievement Award

University of Tuebingen - Germany

AUTHOR PROFILE

EARLY ACADEMIC PURSUITS:

Professor Claus Garbe embarked on his academic journey by obtaining his MD from the Free University of Berlin in 1983. Following this, he pursued board certification in Dermatology and Venereology in 1987. His early academic pursuits laid the foundation for his subsequent groundbreaking work in dermatology and oncology.

PROFESSIONAL ENDEAVORS:

In 1990, Professor Garbe achieved his habilitation, akin to a PhD equivalent, with a focus on the biology of melanoma cells. This marked a significant milestone in his academic career, demonstrating his commitment to advancing the understanding of melanoma, a deadly form of skin cancer. In 1995, he transitioned to Eberhard Karls University, Tuebingen, where he assumed the role of University Professor of Dermatology and Head of the Division of Dermatooncology. This move expanded his scope of influence and provided a platform for furthering his research and clinical endeavors.

CONTRIBUTIONS AND RESEARCH FOCUS ON ONCOLOGY MANAGEMENT AND PREVENTION

Professor Garbe's contributions to the field of dermatology and oncology are extensive and profound. His principal research interests encompass the biology and genetics of melanoma and keratinocyte skin cancers, therapeutic trials in skin diseases, epidemiologic studies, and dermato-histopathology. Through his pioneering research, he has elucidated crucial mechanisms underlying skin cancer development and progression, paving the way for innovative therapeutic approaches and preventive strategies.

IMPACT AND INFLUENCE:

Professor Garbe's impact on the field of dermatologic oncology is unparalleled. His leadership roles in numerous multicenter clinical trials since 1989 have facilitated the translation of research findings into clinical practice, ultimately improving patient outcomes. Moreover, his presidency of the European Association of Dermatologic Oncology (EADO) underscores his influence on a global scale, driving collaboration and innovation in the fight against skin cancer.

ACADEMIC CITATIONS:

With over 800 articles and 17 textbooks to his name, Professor Garbe's scholarly output is prolific. His impressive H-index of 116 points reflects the significant impact of his work within the scientific community. His research findings have been cited extensively, highlighting their relevance and contribution to advancing knowledge in dermatology and oncology.

LEGACY AND FUTURE CONTRIBUTIONS:

Professor Garbe's legacy is characterized by his unwavering dedication to advancing the field of dermatologic oncology. His contributions have not only expanded our understanding of skin cancer but have also shaped clinical practice and guidelines. As he continues to spearhead research efforts and mentor the next generation of scientists and clinicians, his legacy is poised to endure, leaving an indelible mark on the field for years to come.

NOTABLE PUBLICATIONS

Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients. 2024 (2)

Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesia. 2024 (3)

Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma. 2024 (1)

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023. 2023 (6)

Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial. 2023 (2)

PROFESSIONAL ENDEAVORS:

After completing high school, Fatemeh pursued her Medical Doctor (MD) degree at Isfahan University of Medical Sciences, Isfahan, Iran, from February to July 2015. She continued her medical education at Shiraz University of Medical Sciences, Shiraz, Iran, graduating in February 2022. Following her academic achievements, she embarked on a postdoctoral research position at the Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, starting in September 2022.

CONTRIBUTIONS AND RESEARCH FOCUS ON BREAST CANCER SCREENING

Fatemeh actively engaged in various workshops and certifications, showcasing her commitment to expanding her skill set. Notably, she participated in workshops such as Search, Study Design, and Proposal Writing, as well as Python training. Her research focus, primarily in the field of Anesthesiology and Critical Care, is evident in her contributions to poster presentations for the European Society of Radiology (ECR 2023). These contributions cover topics ranging from targeted ultrasound of the breast to the application of shear wave elastography in breast cancer screening.

IMPACT AND INFLUENCE:

Fatemeh's impact extends beyond her academic pursuits. Her poster presentation on "Anti-Inflammatory Therapy in Hair Loss Treatment" at The Second International Conference on Holly Prophet Mohammad’s Tradition reflects her engagement with interdisciplinary topics and potential implications for medical treatments.

LEGACY AND FUTURE CONTRIBUTIONS:

Fatemeh's legacy is marked by her achievements as the first-ranked student in Farzanegan high school and the second-ranked student among Isfahan University of Medical Sciences students in 2015. Her mentorship role in the Medical Physics Research Center and continued contributions to conferences indicate a promising future of further academic and professional accomplishments.